Dosage Forms
DUAVIVE 0.45 mg/20 mg modified-release tablets are oval, biconvex, pink tablets, branded with “0.45/20” in black ink on one side.
Packaging
DUAVIVE 0.45 mg/20 mg is supplied in a carton containing a foil pouch with 1 blister card of 15 or 28 tablets.
Composition
Each 0.45 mg/20 mg modified-release tablet contains 0.45 mg of conjugated estrogens in an extended release core and 20 mg bazedoxifene as bazedoxifene acetate in an immediate release coating.
DUAVIVE contains the following inactive ingredients: ascorbic acid, black iron oxide, calcium phosphate tribasic, hydroxyethylcellulose, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, maltitol, microcrystalline cellulose, poloxamer 188, polyethylene glycol, polydextrose, povidone, powdered cellulose, propylene glycol, red iron oxide, sucrose, sucrose palmitic acid ester, titanium dioxide.
Control #: 210469
January 16, 2019